Subscribe to Newsletter

Subspecialties

Subspecialties Cataract

Beyond Bifocals

In conversation with Thomas Kohnen during the Alcon Multifocal IOL User Meeting in Prague, June 2016

Subspecialties Glaucoma

A Long Term Look at CLASS

| Noa Geffen

The 5-year trial results are in. How safe and effective is the CLASS procedure?

Subspecialties Glaucoma

A User's Guide to SLT

| Dan Lindfield

What benefits can SLT offer, and which patients are eligible?

Subspecialties Glaucoma

The Laser Quest for a Happy Medium

| Roisin McGuigan

Could laser-based treatments offer a happy medium for glaucoma management?

Subspecialties Glaucoma

Video: In Conversation With.....Ingeborg Stalmans

Prof. Stalmans shares her experience of Ultrasound Ciliary Plasty (UCP) for glaucoma treatment

Subspecialties Health Economics and Policy

What Does a Trump Presidency Mean for Obamacare?

| Brian Joondeph

Repeal and replace - what does it actually mean for eyecare?

Subspecialties Glaucoma

The Right Angle

| Hiroshi Ishikawa

Why AS-imaging is my gold standard method for diagnosing and monitoring angle-closure glaucoma.

Subspecialties Retina

No Synergy

| Ruth Steer

Is pegpleranib + ranibizumab better than ranibizumab alone? Phase III results suggest not…

Subspecialties Cataract

The Clear Lens Warden

| Roisin McGuigan

Gene associated with early onset Parkinson’s disease appears to act against cataract formation.

Subspecialties Retina

Same Difference

| Ruth Steer

Real-world observational study comparing ranibizumab and aflibercept shows similar outcomes.

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer element

This new disclaimer element is now part of all brands. It is editable on the start page and will be shown on all pages

Once confirmed we store a cookie to not show the disclaimer again.